Related Experiment Video
Updated: Aug 8, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Adenovirus DNA binding protein inhibits SrCap-activated CBP and CREB-mediated transcription
Xiequn Xu1, Vera Tarakanova, John Chrivia
1Department of Molecular Microbiology and Immunology, Saint Louis University Health Sciences Center, Saint Louis, MO 63104, USA.
Abstract:
The SNF2-related CBP activator protein (SrCap) is a potent activator of transcription mediated by CBP and CREB. We have previously demonstrated that the Adenovirus 2 DNA Binding Protein (DBP) binds to SrCap and inhibits the transcription mediated by the carboxyl-terminal region of SrCap (amino acids 1275-2971). We report here that DBP inhibits the ability of full-length SrCap (1-2971) to activate transcription mediated by Gal-CREB and Gal-CBP. In addition, DBP also inhibits the ability of SrCap to enhance Protein Kinase A (PKA) activated transcription of the enkaphalin promoter. DBP was found to dramatically inhibit transcription of a mammalian two-hybrid system that was dependent on the interaction of SrCap and CBP binding domains. We also found that DBP has no effect on transcription mediated by a transcriptional activator that is not related to SrCap, indicating that our reported transcriptional inhibition is specific for SrCap and not due to nonspecific effects of DBP's DNA binding activity on the CAT reporter plasmid. Taken together, these results suggest a model in which DBP inhibits cellular transcription mediated by the interaction between SrCap and CBP.
Insights
Adenovirus 2 DNA Binding Protein (DBP) inhibits transcription mediated by SNF2-related CBP activator protein (SrCap). DBP specifically blocks SrCap
Area of Science:
- Molecular Biology
- Gene Regulation
- Transcription Factors
Background:
- SNF2-related CBP activator protein (SrCap) is a key mediator of transcription involving CBP and CREB.
- Adenovirus 2 DNA Binding Protein (DBP) has been shown to bind SrCap and inhibit its carboxyl-terminal activity.
Purpose of the Study:
- To investigate the effect of DBP on the transcriptional activity of full-length SrCap.
- To determine if DBP's inhibitory effect on SrCap is specific.
Main Methods:
- Assessed the impact of DBP on SrCap-mediated transcription using Gal-CREB and Gal-CBP systems.
- Evaluated DBP's effect on Protein Kinase A (PKA)-activated transcription of the enkephalin promoter.
- Utilized a mammalian two-hybrid system to examine DBP's inhibition of SrCap-CBP interactions.
- Tested DBP's effect on a non-SrCap-related transcriptional activator to assess specificity.
Main Results:
- DBP significantly inhibits the transcriptional activation mediated by full-length SrCap.
- DBP suppresses PKA-activated transcription of the enkephalin promoter via SrCap.
- DBP dramatically inhibits transcription in a mammalian two-hybrid system dependent on SrCap-CBP interaction.
- DBP's inhibitory effect is specific to SrCap, as it does not affect unrelated transcriptional activators.
Conclusions:
- DBP acts as a specific inhibitor of SrCap-mediated transcription.
- The findings support a model where DBP interferes with the SrCap-CBP interaction to inhibit cellular transcription.
More Related Videos
10:22Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Related Concept Videos
RNA Polymerase II Accessory Proteins
Cell Specific Gene Expression
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Inhibitors Of Virion Release